Imara is a clinical-stage biotechnology company focused on developing new therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin.

SP Angel Morning View - PBoC cuts rates to support economic growth

The exclusive licence will see the strain’s inclusion into dietary supplements formulation available to customers in the United States and Canada.

Advanced Oncotherapy said the installation is expected to start in 2023, in line with the completion of construction works at the hospital.